Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
破譯代碼：了解kymera therapeutics的分析師評論
The standing of Kymera Therapeutics among financial experts...During the last three months, 7 analysts shared their evaluations of Kymera Therapeutics (NASDAQ:KYMR), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，7位分析師分享了他們對Kymera Therapeutics（納斯達克股票代碼：KYMR）的評估，揭示了從看漲到看跌的不同前景。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.86, a high estimate of $65.00, and a low estimate of $36.00. This upward trend is apparent, with the current average reflecting a 26.58% increase from the previous average price target of $38.60.
分析師12個月目標股價的見解已經公佈，平均目標股價爲48.86美元，最高估計爲65.00美元，低估值爲36.00美元。這種上升趨勢顯而易見，當前的平均價格較之前的38.60美元的平均目標股價上漲了26.58％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The standing of Kymera Therapeutics among financial experts...
通過對分析師近期...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間